Income 235.16 1.41 329.90 1.94 318.24 1.85 Total Revenue 16,701.67 100.00 17,022.92 100.00 17,246.71 100.00 Cost of Sales (14,463.26) (86.60) (14,191.28) (83.37) (14,150.92) (82.05) Selling and
from rental and rendering of services from new rental spaces and improved occupancy rates, and decreased selling and distribution expenses from improved cost management • Operating revenue increased by
financing cost by 42.6% YoY, in line with the lower amount of interest-bearing debt whilst cost of debt remains at a low level. Meanwhile, share of profit from investments declined 1.7% YoY due to the
discouraged by economics. Lose sales opportunities in relation to a low level of stocks due to a limited warehouse space. Other income 2.8 6.1 117.9% A gain and profit in exchange rate comparing to the same
a result, the refinery business recorded an Inventory Loss of THB 1,253 million (including a reversion of lower of cost or market (LCM) THB 689 million) in 2019, which adversely affected the
expenses, finance cost and taxes 24.57 21.74 17.51 23.29 (7.06) (28.73) Distribution costs 1.82 1.61 1.84 2.45 0.02 1.10 Administrative expenses 9.82 8.69 9.76 12.98 (0.06) (0.61) Profit before finance cost
for sales staff, traveling and vehicle expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
expense for sales staff, cost of advertisement media for product promotion, compensation paid to Zuellig Pharma Ltd. under the Distribution Agreement and compensation for distribution of the Company’s
% 38.0 129.4% Total revenues from sales and services 156.3 100.0% 165.1 100.0% 8.9 5.7% Cost of Rental 115.2 73.7% 8.7 5.3% -106.5 -92.5% Cost of Sales 19.8 12.7% 45.0 27.2% 25.1 126.7% Total cost of sales